Victrex plc -8.2% potential downside indicated by Barclays

Victrex plc with ticker (LON:VCT) now has a potential downside of -8.2% according to Barclays.



Barclays set a target price of 2,140 GBX for the company, which when compared to the Victrex plc share price of 2,316 GBX at opening today (29/10/2021) indicates a potential downside of -8.2%. Trading has ranged between 1,798 (52 week low) and 2,720 (52 week high) with an average of 103,687 shares exchanging hands daily. The market capitalisation at the time of writing is £2,007,234,364.

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. The Company offers polyetheretherketone (PEEK) and polyaryletherketone (PAEK)-based polymer solutions. The Company’s geographical locations include the United Kingdom; Europe, Middle East and Africa (EMEA); Americas, and Asia-Pacific. Its solutions are used in a range of applications, such as braking systems in automotive market, seal rings in energy market, mobile devices in electronics market and implanted devices in medical market. Its subsidiaries include Victrex Manufacturing Limited and Invibio Limited.